Pfizer and BioNTech have announced a nearly $2 billion agreement with the U.S. government for doses of a potential COVID-19 vaccine.
Under the agreement the companies detailed on Wednesday, the U.S. will get 100 million doses of a COVID-19 candidate after it's manufactured if it receives approval or authorization from the Food and Drug Administration. The U.S. will pay $1.95 billion for doses of the potential vaccine for Americans to receive for free and "also can acquire up to an additional 500 million doses," the announcement said.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
-
Bergerac: 'darker' reboot of the eighties crime dramaThe Week Recommends Irish actor Damien Molony takes over from John Nettles as the Jersey detective
-
Pamela Anderson is 'transfixing' in The Last ShowgirlThe Week Recommends 'Quietly touching' film about a Las Vegas showgirl facing the end of her career
-
Is it time to ban smacking in England?Today's Big Question Experts are calling for 'Victorian-era punishment' to be scrapped, but the government isn't ready to act
-
Texas outbreak brings 1st US measles death since 2015Speed read The outbreak is concentrated in a 'close-knit, undervaccinated' Mennonite community in rural Gaines County
-
Mystery illness spreading in Congo rapidly kills dozensSpeed Read The World Health Organization said 53 people have died in an outbreak that originated in a village where three children ate a bat carcass
-
Ozempic can curb alcohol cravings, study findsSpeed read Weight loss drugs like Ozempic and Wegovy may also be helpful in limiting alcohol consumption
-
New form of H5N1 bird flu found in US dairy cowsSpeed Read This new form of bird flu is different from the version that spread through herds in the last year
-
Microplastics accumulating in human brains, study findsSpeed Read The amount of tiny plastic particles found in human brains increased dramatically from 2016 to 2024
-
FDA approves painkiller said to thwart addictionSpeed Read Suzetrigine, being sold as Journavx, is the first new pharmaceutical pain treatment approved by the FDA in 20 years
-
Study finds possible alternative abortion pillSpeed Read An emergency contraception (morning-after) pill called Ella could be an alternative to mifepristone for abortions
-
California declares bird flu emergencySpeed Read The emergency came hours after the nation's first person with severe bird flu infection was hospitalized
